NCT03897543Phase 1, phase 2Completed

ABX196 in Combination With Nivolumab in Patients With Hepatocellular Carcinoma

Study sponsor: Abivax S.A. · ABVX

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2022-04-14Actual
Enrollment · participants10Actual
Source updated2026-09-29Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.